Avantor Inc (AVTR)
20.79
-0.36
(-1.70%)
USD |
NYSE |
Nov 15, 12:47
Avantor Cash and Short Term Investments (Quarterly): 285.30M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 285.30M |
June 30, 2024 | 272.60M |
March 31, 2024 | 234.90M |
December 31, 2023 | 262.90M |
September 30, 2023 | 236.90M |
June 30, 2023 | 236.40M |
March 31, 2023 | 294.60M |
December 31, 2022 | 372.90M |
September 30, 2022 | 265.60M |
June 30, 2022 | 237.50M |
March 31, 2022 | 283.60M |
December 31, 2021 | 301.70M |
Date | Value |
---|---|
September 30, 2021 | 1.426B |
June 30, 2021 | 223.00M |
March 31, 2021 | 172.50M |
December 31, 2020 | 286.60M |
September 30, 2020 | 370.50M |
June 30, 2020 | 415.30M |
March 31, 2020 | 346.30M |
December 31, 2019 | 186.70M |
September 30, 2019 | 173.90M |
June 30, 2019 | 164.60M |
March 31, 2019 | 143.90M |
December 31, 2018 | 184.70M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
172.50M
Minimum
Mar 2021
1.426B
Maximum
Sep 2021
335.60M
Average
278.10M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Revvity Inc | 1.230B |
Bruker Corp | 148.10M |
Azenta Inc | 595.84M |
Harvard Bioscience Inc | 4.569M |
Bionano Genomics Inc | 18.94M |